23. Dezember 2026
FDA PDUFA target action date for anitocabtagene autoleucel, a BLA from Arcellx and Gilead. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA-PDUFA-Entscheidungstermine-Kalender